scispace - formally typeset
R

Ryan G. Toedebusch

Researcher at University of Missouri

Publications -  32
Citations -  958

Ryan G. Toedebusch is an academic researcher from University of Missouri. The author has contributed to research in topics: Adipose tissue & Medicine. The author has an hindex of 13, co-authored 29 publications receiving 700 citations. Previous affiliations of Ryan G. Toedebusch include Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms

TL;DR: It is proposed that physical inactivity could be considered a behavior selected by evolution for resting, and also selected to be reinforcing in life-threatening situations in which exercise would be dangerous.
Book ChapterDOI

Endurance Exercise and the Regulation of Skeletal Muscle Metabolism.

TL;DR: Recent evidence suggests that the energetic demands of muscle contraction are by themselves stronger controllers of body weight and glucose control than is muscle mitochondrial content.
Journal ArticleDOI

Phenotypic and molecular differences between rats selectively bred to voluntarily run high vs. low nightly distances

TL;DR: Interestingly, HVRs presented less Oprd1 mRNA, which ties in to potential differences in dopaminergic signaling between lines, which provides further evidence as to how exercise may be mechanistically regulated.
Journal ArticleDOI

Nucleus accumbens neuronal maturation differences in young rats bred for low versus high voluntary running behaviour

TL;DR: Neuron maturation in the nucleus accumbens is related to low running voluntary behaviour in the model; this allows researchers to understand the potential neural mechanisms that underlie the motivations for low physical activity behaviour.
Journal ArticleDOI

Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures.

TL;DR: This review focuses on the emerging cellular and molecular markers that define sex differences in diabetic cardiomyopathy based on the recent clinical and pre-clinical evidence, and discusses miR-208a, MED13, and AT2R, which may provide new therapeutic targets with hopes to develop novel treatment paradigms to treat diabetic carduomyopathy uniquely between men and women.